Endevica Bio
Endevica Bio's lead drug candidate is a peptide therapeutic for treating cachexia due to cancer and other chronic conditions. Phase 1 Clinical trials in the US are underway.
Endevica Bio Offices
OnSite Workspace
Employees work from physical offices.
Typical time on-site:
None
Columbia, Missouri, USA
